Inventor · disambiguated record
Georges Pasquet
Also filed as: PASQUET GEORGES · PASQUET GEORGES R · PASQUET GEORGES RENE
10 granted patents·2 pending applications·82 citations·filing 1989–2015
87Inventor score
Top patents by PatentIndex Score
12 records- 0182US7402585B2Substituted quinazoline derivatives as inhibitors of aurora kinasesASTRAZENECA AB·Filed 2002·Granted Jul 22, 2008·13 cites·33 claims
- 0277US9018191B2Phosphonoxy quinazoline derivatives and their pharmaceutical useHERON NICOLA MURDOCH·Filed 2012·Granted Apr 28, 2015·2 cites·6 claims
- 0376US7262201B1Quinazoline derivativesASTRAZENECA AB·Filed 1999·Granted Aug 28, 2007·43 cites·10 claims
- 0471US5013731ACephalosporin compoundsICI PHARMA·Filed 1990·Granted May 7, 1991·14 cites·20 claims
- 0560US7691867B2Chemical compoundsASTRAZENECA AB·Filed 2004·Granted Apr 6, 2010·1 cites·21 claims
- 0659US8268841B2Phosphonoxy quinazoline derivatives and their pharmaceutical useHERON NICOLA MURDOCH·Filed 2009·Granted Sep 18, 2012·0 cites·3 claims
- 0758US9567358B2Methods of treatment using N-(3-fluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamideASTRAZENECA AB·Filed 2015·Granted Feb 14, 2017·0 cites·2 claims
- 0857US2009215770A1Substituted Quinazoline Derivatives as Inhibitors of Aurora KinasesASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 0952US5049558ACephalosporin derivativesICI PLC·Filed 1989·Granted Sep 17, 1991·6 cites·20 claims
- 1047US5254679ACephalosporin intermediatesICI PLC·Filed 1991·Granted Oct 19, 1993·3 cites·17 claims
- 1138US2006135541A1(3-((Quinazolin-4-yl) amino)-1h-pyrazol-1-yl)acetamide derivatives and related compounds as aurora kinase inhibitors for the treatment of proliferative diseases such as cancerASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 1225US5053500AIntermediates for the preparation of beta-lactam antibioticsICI PLC·Filed 1990·Granted Oct 1, 1991·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Georges Pasquet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →